Cytori Therapeutics Adds To Board

San Diego-based biopharmaceuticals developer Cytori said Wednesday that it has named Gail K. Naughton as a new, independent director at the company. Naughton was the co-founder of Advanced Tissue Sciences, where she also served as President, Chief Operating Officer, and Director. She also was the Dean of the College of Business Administration at San Diego State University. Naughton currently serves as CEO and Chairman of Histogen. Cytori Therapeutics is focused on treating cardiovascular disease and other conditions.